Assessment and management of nausea and vomiting in cancer survivors
JM Tipton - The Nurse Practitioner, 2023 - journals.lww.com
Nausea and vomiting may occur in cancer survivors during or independent of treatment. A
complete assessment is necessary to determine the etiology and to plan specific and …
complete assessment is necessary to determine the etiology and to plan specific and …
The why and how of maintaining hydration during cancer therapy
Maintaining adequate hydration is important in patients receiving cancer therapy.
Challenges exist, secondary to limited clinical guidelines of hydration in patients with …
Challenges exist, secondary to limited clinical guidelines of hydration in patients with …
[HTML][HTML] Prevalence of Breakthrough Chemotherapy-Induced Nausea Vomiting in Patients on Highly Emetogenic Chemotherapy: A Single-Center Observational Study
PP Lokkur, N Mahanta, NK Kalita, H Deka… - Oncology Journal of …, 2021 - journals.lww.com
Objectives: The present study was planned to determine the prevalence of breakthrough
CINV in patients on highly emetogenic chemotherapy (HEC) and to evaluate the need for …
CINV in patients on highly emetogenic chemotherapy (HEC) and to evaluate the need for …
[HTML][HTML] Granisetron Extended-Release Subcutaneous Injection versus Palonosetron Infusion for CINV Prevention: Cost Comparison of Unscheduled Hydration
M Barnes, G Calcanes, MC Mosier… - American health & …, 2021 - ncbi.nlm.nih.gov
Background Granisetron extended-release subcutaneous (SC) injection is a novel
formulation of granisetron for the prevention of acute and delayed chemotherapy-induced …
formulation of granisetron for the prevention of acute and delayed chemotherapy-induced …